Your session is about to expire
← Back to Search
Nutrition Education Program
Plant-Based Diet for Type 2 Diabetes (DROP Trial)
N/A
Recruiting
Led By Neal Barnard, MD
Research Sponsored by Physicians Committee for Responsible Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Prior diagnosis of type 2 diabetes mellitus
Be older than 18 years old
Must not have
Lack of English fluency
Unstable medical or psychiatric illness
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing an online course that teaches people about eating a plant-based diet. It aims to help community members improve their blood sugar levels, lose weight, and lower cholesterol. The study will see if these health benefits make the program useful for doctors and patients.
Who is the study for?
The DROP Study is for U.S. adults with type 2 diabetes who can maintain their current medication regimen. Participants must be fluent in English and not use recreational drugs, be pregnant, or plan to become pregnant during the study. They should also be able to participate fully in the program.
What is being tested?
This trial tests a 20-week online education program promoting a plant-based diet for people with type 2 diabetes. It aims to see if this approach is practical and effective at lowering blood sugar levels, weight, and cholesterol in a community setting.
What are the potential side effects?
While not explicitly listed, potential side effects may include changes in digestion due to dietary adjustments, possible nutrient deficiencies without proper planning of the plant-based diet, and initial withdrawal symptoms from reducing certain foods.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been diagnosed with type 2 diabetes.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am not fluent in English.
Select...
I do not have any unstable medical or mental health conditions.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Glycated hemoglobin
Secondary study objectives
LDL cholesterol
body weight
medication usage
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Vegan dietExperimental Treatment1 Intervention
All participants will follow a low-fat vegan diet. There are no other study arms or control group.
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for Type 2 Diabetes include dietary changes, medications, and lifestyle modifications. Plant-based nutrition, as studied in the Plant-Based Nutrition Education Program, emphasizes high intake of fruits, vegetables, whole grains, and legumes, which can improve insulin sensitivity and reduce inflammation.
This dietary approach helps lower glycated hemoglobin levels, body weight, and cholesterol, which are crucial for managing diabetes. Medications like metformin work by reducing glucose production in the liver and improving insulin sensitivity.
Lifestyle changes, including regular physical activity, enhance glucose uptake by muscles and improve overall metabolic health. These treatments are vital for Type 2 Diabetes patients as they help maintain blood glucose levels, prevent complications, and improve quality of life.
A Group-Based Community Reinforcement Approach of Cognitive Behavioral Therapy Program to Improve Self-Care Behavior of Patients With Type 2 Diabetes.Long-term non-pharmacological weight loss interventions for adults with type 2 diabetes mellitus.Sustaining Effect of Intensive Nutritional Intervention Combined with Health Education on Dietary Behavior and Plasma Glucose in Type 2 Diabetes Mellitus Patients.
A Group-Based Community Reinforcement Approach of Cognitive Behavioral Therapy Program to Improve Self-Care Behavior of Patients With Type 2 Diabetes.Long-term non-pharmacological weight loss interventions for adults with type 2 diabetes mellitus.Sustaining Effect of Intensive Nutritional Intervention Combined with Health Education on Dietary Behavior and Plasma Glucose in Type 2 Diabetes Mellitus Patients.
Find a Location
Who is running the clinical trial?
Physicians Committee for Responsible MedicineLead Sponsor
29 Previous Clinical Trials
2,475 Total Patients Enrolled
Neal Barnard, MDPrincipal InvestigatorPhysicians Committee for Responsible Medicine
9 Previous Clinical Trials
1,143 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have been diagnosed with type 2 diabetes.I am not fluent in English.I am of legal age to participate in this trial based on my state's law.You have used recreational drugs in the last 6 months.I do not have any unstable medical or mental health conditions.You can't keep taking your current medications as prescribed.I am willing and able to participate in all parts of the study.
Research Study Groups:
This trial has the following groups:- Group 1: Vegan diet
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Type 2 Diabetes Patient Testimony for trial: Trial Name: NCT05572502 — N/A